Annotation Detail for SRL

Basic Information
Top
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D002857 |
Chromium |
LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in increased expression of SRL mRNA] | affects binding|increases expression|increases reaction | 16940432
|
D004317 |
Doxorubicin |
Doxorubicin results in increased expression of SRL protein | increases expression | 16144979
|
D009525 |
Niacin |
LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in increased expression of SRL mRNA] | affects binding|increases expression|increases reaction | 16940432
|
C023036 |
perfluorooctanoic acid |
perfluorooctanoic acid results in increased expression of SRL mRNA | increases expression | 17560707
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
2.64 | 17418594 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
5.05 | 21441931 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
5.42 | 14601052 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
4.20 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Chromium |
2.72 | 15986119 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
2.72 | 17426702 18628466 18382427 15668708 16595493 15136595 18234424 16115903 15634643 17369602 16826403 15939500 16322301 17983394 16264153 19526202 15993339 16096432 16935488 11325840 18695136 15994142 15567936 15692762 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
5.53 | 16051944 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
2.26 | 16234567 16023760 18059187 17876044 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
3.31 | 16201981 1485588 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
2.72 | 6189445 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.77 | 17308081 16455267 17519947 15505089 17329180 17382496 17007740 16269455 16364871 17974986 15476868 16651473 17131338 16109756 17928571 15792986 16278810 16612575 18627295 16952015 16731534 16242529 17924179 15811867 17351982 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
3.05 | 17334414 16243910 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
2.15 | 18259882 18802399 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
2.52 | 17416283 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
3.96 | 18602426 |
MESH:D004487 |
Edema |
|
perfluorooctanoic acid |
4.00 | 17259670 12083418 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
3.69 | 17359293 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.88 | 18037988 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
5.22 | 19069698 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
3.59 | 17150277 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
3.78 | 15692506 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.75 | 12587719 16707910 17888722 18674790 16879835 16144979 14766674 16244372 16330681 17875725 16244371 18006777 16495754 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
3.56 | 17481944 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
4.33 | 15692506 |
MESH:D006529 |
Hepatomegaly |
|
perfluorooctanoic acid |
4.65 | 3609246 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
3.77 | 17606976 18501091 15147373 |
MESH:D006930 |
Hyperalgesia |
|
perfluorooctanoic acid |
4.17 | 12083418 |
MESH:D007249 |
Inflammation |
|
perfluorooctanoic acid |
3.23 | 12083418 |
MESH:D007674 |
Kidney Diseases |
|
Chromium |
7.37 | 17934191 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
7.37 | 15699352 15369732 16775033 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
4.58 | 16707910 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.88 | 16085563 |
MESH:D007984 |
Leydig Cell Tumor |
|
perfluorooctanoic acid |
5.86 | 8812269 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
2.16 | 16595196 16439617 |
MESH:D008113 |
Liver Neoplasms |
|
perfluorooctanoic acid |
3.03 | 18709148 14757943 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
3.24 | 17085340 16842330 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
2.15 | 17418594 6189445 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
3.73 | 16098063 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
4.13 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
5.13 | 15621674 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
3.26 | 15458769 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
2.33 | 16827129 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
3.18 | 17638057 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.93 | 15792986 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
5.42 | 17415656 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
3.08 | 15857846 19429709 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
3.08 | 18259882 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
5.33 | 16899518 16636307 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
4.37 | 15640375 16889571 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.43 | 15555623 |
MESH:D052556 |
Niemann-Pick Disease, Type C |
|
perfluorooctanoic acid |
5.51 | 9802331 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.44 | 15930896 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.88 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.88 | 17638057 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
perfluorooctanoic acid |
5.02 | 17132714 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
3.49 | 16729912 15897917 16868541 18437689 15749863 16888761 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.78 | 17922066 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
4.38 | 17203757 15625365 16767912 15675481 18313854 17710206 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.75 | 16326096 14601052 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
5.42 | 17846226 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
3.11 | 15692506 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
5.13 | 17203757 15625365 16767912 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
3.67 | 17909728 16010429 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
2.88 | 17653716 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.78 | 17678736 17334414 17638931 16364871 |